Showing results (431-440 of 702) with videos related to
Sort By:
Pageof 71
Experimental Physiology|August 11, 2023
Implementation of a coagulation component into a phosphate kinetics model in haemodialysis therapy: A tool for detection of clotting problems?Sisse H Laursen, Lise Boel, Lisbet Brandi, et al.Pharmacology Research & Perspectives|March 7, 2024
Adherence to newer second-line oral antidiabetic drugs among people with type 2 diabetes-A systematic reviewNynne Sophie Holdt-Caspersen, Claus Dethlefsen, Peter Vestergaard, et al.Clinical Epidemiology|October 14, 2024
Incidence of Graves' Disease with Validation and Completeness of the Diagnosis for Registry Extracts in the Danish National Patient RegisterFrederik Østergaard Klit, Jakob Dal, Stine Linding Andersen, et al.Diabetes Research and Clinical Practice|April 19, 2025
Assessment of basal insulin adherence in people with type 2 diabetes in telemonitoring: Post-hoc analysis of novel data modalities including insulin injection dataJannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 7, 2017
Longer term effectiveness of inpatient multidisciplinary rehabilitation on health-related quality of life in MS patients: a pragmatic randomized controlled trial - The Danish MS Hospitals Rehabilitation StudyFinn Boesen, Michael Nørgaard, Philipp Trénel, et al.Journal of Diabetes Science and Technology|May 28, 2020
Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 DiabetesMorten Hasselstrøm Jensen, Simon Lebech Cichosz, Irl B Hirsch, et al.Plos One|April 11, 2015
Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panelMorten Stilund, Mikkel Carstensen Gjelstrup, Thor Petersen, et al.Journal of Diabetes|March 26, 2025
Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry-Based Case-Control StudyAsger Ahlmann Bech, Mia Daugaard Madsen, Annika Vestergaard Kvist, et al.Plos One|June 3, 2014
Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosisMorten Stilund, Ann-Kathrin Reuschlein, Tove Christensen, et al.Studies in Health Technology and Informatics|August 23, 2024
Development of a Basal Insulin Titration System to Support Healthcare Providers in Treatment of People with Type 2 Diabetes: Preliminary ResultsCamilla H N Thomsen, Stine Hangaard, Thomas Kronborg, et al.Pageof 71